Home › Parkinson's Disease › NCT03992625

Clinical Outcomes for Deep Brain Stimulation

Clinical Outcomes for Deep Brain Stimulation for Parkinson Disease, Tremor, and Dystonia

Who can join

All ages · All sexes

Inclusion Criteria:

* Levodopa responsive Parkinson disease OR
* Medically refractory Essential Tremor OR
* Medically refractory Dystonia

Exclusion Criteria:

* Dementia (Mattis Dementia Rating Scale \<130)
* Structural abnormalities precluding intracranial surgery

About the study

The object of this study is to longitudinally collect clinical outcomes of patients receiving deep brain stimulation for movement disorders with the objective of making retrospective comparisons and tracking of risks, benefits, and complications.

What is being tested

• Deep Brain Stimulation (device)

Sponsor: Washington University School of Medicine · Participants: 1,000 · Started: Jan 3, 2011

Contact the study team

• Mwiza Ushe, M.D. · Phone: 3143625262

Official record on ClinicalTrials.gov — NCT03992625

Locations in the U.S.

Conditions

• Parkinson's Disease
• Essential Tremor
• Dystonia

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.